financetom
Business
financetom
/
Business
/
New Generation Consumer Group's Signature Apps in Talks to Acquire Revenue-Generating Subscription App Companies
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
New Generation Consumer Group's Signature Apps in Talks to Acquire Revenue-Generating Subscription App Companies
Oct 29, 2025 5:52 AM

PHOENIX, AZ / ACCESS Newswire ( ACCS ) / October 29, 2025 / New Generation Consumer Group ( NGCG ) announced today that its subsidiary, Signature Apps, is in active discussions to acquire multiple revenue-generating app and service companies. The target companies operate on subscription-based models, delivering consistent, recurring revenues that align with Signature Apps' strategy to scale its digital product suite and expand its customer base.

The contemplated acquisitions are intended to immediately strengthen Signature Apps' recurring revenue profile while adding established subscriber communities and proven monetization models. Management believes integrating these subscription businesses will accelerate cash flow growth and support a faster path to profitability.

"The revenue potential from these acquisitions is tremendous," said Jacob DiMartino, CEO of New Generation Consumer Group ( NGCG ). "This initiative reflects how serious we are about transforming Signature Apps into a multi-million-dollar revenue-generating company. Our goal is to expand market reach and deliver meaningful shareholder value in the near term - these strategic moves demonstrate our commitment to growth and results."

Signature Apps is targeting companies that provide complementary services and that can be integrated smoothly into its existing platform and marketing channels. New Generation Consumer Group ( NGCG ) expects the potential acquisitions to provide both short-term revenue uplift and long-term strategic value through cross-sell and upsell opportunities across its product portfolio.

Further details regarding the acquisition talks and any definitive agreements will be disclosed as they are finalized and in accordance with applicable disclosure requirements.

About New Generation Consumer Group ( NGCG ) / Signature Apps

New Generation Consumer Group ( NGCG ) is a consumer-focused technology company seeking to build and acquire subscription-based digital products that generate recurring revenue and deliver value to end users and shareholders. Signature Apps is the company's operating arm focused on developing, marketing, and scaling mobile and web subscription services.

Forward-Looking Statements:

This release includes forward-looking statements that involve risks and uncertainties. Actual results may differ materially due to various factors, including the outcome of negotiations, market conditions, and other risks described in the company's filings.

Contact:

Investor Relations

New Generation Consumer Group ( NGCG )

Phoenix, Arizona

Email: [email protected]

SOURCE: Signature Apps

View the original press release on ACCESS Newswire ( ACCS )

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Illumina Starts Pilot Program With Partners to Generate Proteomics Data
Illumina Starts Pilot Program With Partners to Generate Proteomics Data
Jan 13, 2025
04:39 AM EST, 01/13/2025 (MT Newswires) -- Illumina ( ILMN ) said Monday it started a pilot proteomics program to analyze 50,000 UK Biobank samples in partnership with deCODE Genetics, Standard BioTools, Tecan, GSK (GSK), Johnson & Johnson ( JNJ ) , and Novartis ( NVS ) . Under the collaboration, deCODE Genetics will process the samples from the UK...
Teva Pharmaceuticals International Enters Collaboration to Commercialize Eye Disease Treatment
Teva Pharmaceuticals International Enters Collaboration to Commercialize Eye Disease Treatment
Jan 13, 2025
04:32 AM EST, 01/13/2025 (MT Newswires) -- Teva Pharmaceutical Industries' ( TEVA ) Teva Pharmaceuticals International subsidiary said Monday it has entered into a collaboration with Klinge Biopharma and Formycon for the semi-exclusive commercialization of FYB203, Formycon's biosimilar candidate to Eylea, in Israel and Europe, excluding Italy. Financial terms were not disclosed. Klinge has licensed the exclusive global commercialization rights...
Caribou Biosciences Starts Phase 1 Trial for Lupus Drug Candidate
Caribou Biosciences Starts Phase 1 Trial for Lupus Drug Candidate
Jan 13, 2025
04:47 AM EST, 01/13/2025 (MT Newswires) -- Caribou Biosciences ( CRBU ) said Sunday it initiated the phase 1 trial evaluating its experimental therapy, CB-010, in patients with lupus nephritis and extrarenal lupus. Additionally, the company said it expects to report data from a study of CB-010 to treat certain large B cell lymphoma patients in the first half of...
BP Azerbaijan says working to resume work of Shah Deniz platform as soon as possible
BP Azerbaijan says working to resume work of Shah Deniz platform as soon as possible
Jan 13, 2025
BAKU, Jan 13 (Reuters) - BP is working to resolve technical problems at the Shah Deniz Alfa (SDA) platform and hopes to resume normal operations as soon as possible, the company told Reuters on Monday. BP suspended work of the platform on Friday after detecting a technical issue at the subsea gas condensate export line between the platform and the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved